Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

    Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi
    13-09-2023
    https://doi.org/10.4081/dr.2023.9839
    2881
    PDF: 1022
    HTML: 40
  • Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

    Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi
    29-12-2022
    https://doi.org/10.4081/dr.2023.9613
    1850
    PDF: 571
    HTML: 103
  • Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

    Paolo Dapavo, Matteo Megna, Marina Talamonti
    09-08-2024
    https://doi.org/10.4081/dr.2024.9999
    1892
    PDF: 780
    HTML: 110
  • Treatment satisfaction among patients with psoriasis in Saudi Arabia

    Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi
    15-04-2024
    https://doi.org/10.4081/dr.2024.9967
    1155
    PDF: 669
    HTML: 55
  • Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

    Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi
    14-03-2022
    https://doi.org/10.4081/dr.2022.9091
    2682
    PDF: 664
    HTML: 17
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

    Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino
    25-06-2020
    https://doi.org/10.4081/dr.2020.8642
    1444
    PDF: 780
    HTML: 22
  • Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

    Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno
    28-12-2021
    https://doi.org/10.4081/dr.2022.9454
    4179
    PDF: 696
    APPENDIX: 200
    HTML: 24
  • Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

    Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota
    11-11-2024
    https://doi.org/10.4081/dr.2024.10140
    1120
    PDF: 588
    SUPPLEMENTARY MATERIAL: 190
    HTML: 24
  • Nightmares caused by isotretinoin in treating hidradenitis suppurativa: a case report and clinical insights

    Fawaz Aljehani, Shumukh Alqahtani, Sara Alharbi, Seham Alsulami
    06-12-2024
    https://doi.org/10.4081/dr.2024.10171
    1900
    PDF: 507
    HTML: 66
  • Hidradenitis suppurativa: state-of-the-art review and update

    Marco Virone, Elena Zappia, Alberto Di Caro, Davide Carlesimo, Nicoletta Bernardini, Giovanni Pellacani, Antonio Giovanni Richetta, Steven Paul Nisticò, Annunziata Dattola
    27-08-2025
    https://doi.org/10.4081/dr.2025.10328
    1439
    PDF: 913
    HTML: 29
  • New and emerging therapies in cutaneous T-cell lymphoma

    Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino
    02-10-2024
    https://doi.org/10.4081/dr.2024.10002
    1250
    PDF: 711
    HTML: 113
  • Refractory pityriasis rubra pilaris treated with abrocitinib

    Filip Rob
    09-01-2025
    https://doi.org/10.4081/dr.2025.10105
    558
    PDF: 347
    HTML: 28
  • Eosinophilic annular erythema: four additional cases and a review of the literature on therapeutic options

    Andrea Corio, Simona Sola, Iris Zalaudek, Cesare Massone
    16-01-2026
    https://doi.org/10.4081/dr.2026.10168
    1052
    PDF: 457
    SUPPLEMENTARY MATERIAL: 14
    HTML: 0
  • Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

    Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    19-05-2023
    https://doi.org/10.4081/dr.2023.9692
    1184
    PDF: 585
    HTML: 29
  • Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

    Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło
    22-05-2023
    https://doi.org/10.4081/dr.2023.9630
    1133
    PDF: 597
    HTML: 105
  • The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination

    Georgi Tchernev, Simona Kordeva, Heily Kirilova, Valentina Broshtilova
    01-03-2023
    https://doi.org/10.4081/dr.2023.9636
    1302
    PDF: 630
    HTML: 78
  • Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

    Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan
    21-11-2022
    https://doi.org/10.4081/dr.2022.9492
    1847
    PDF: 708
    HTML: 92
  • Molluscum contagiosum eruption during therapy with methotrexate and abatacept: a clinical and dermoscopic case study

    Franca Taviti, Alessandra Calcinai, Federica Scarfì
    21-03-2022
    https://doi.org/10.4081/dr.2022.9259
    1187
    PDF: 561
    HTML: 582
  • Herpes vegetans, an atypical herpes lesion in HIV patient: A case report

    Sondang P. Sirait, Wresti Indriatmi
    14-03-2022
    https://doi.org/10.4081/dr.2022.9180
    2773
    PDF: 909
    HTML: 27
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1264
    PDF: 876
    HTML: 51
  • Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

    Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly
    21-11-2022
    https://doi.org/10.4081/dr.2022.9265
    1592
    PDF: 477
    HTML: 41
  • Erythrodermic psoriasis improved by tildrakizumab

    Giampaolo Trevisan, Lerica Germi, Luigi Naldi
    23-11-2022
    https://doi.org/10.4081/dr.2022.9448
    1382
    PDF: 647
    HTML: 29
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1468
    PDF: 704
    HTML: 149
  • Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

    Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
    30-05-2025
    https://doi.org/10.4081/dr.2025.10414
    942
    PDF: 489
    HTML: 55
  • Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

    Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi
    16-10-2025
    https://doi.org/10.4081/dr.2025.10588
    503
    PDF: 248
    HTML: 5
1 - 25 of 52 items 1 2 3 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.